News | Cardiovascular Business | January 12, 2016

GE Healthcare Selects Chicago for Global Headquarters

Move from U.K. brings industry giant closer to operations in Chicago and Milwaukee, international transportation hub

GE Healthcare, headquarters move, Chicago

January 12, 2016 — GE Healthcare announced that it has chosen Chicago as its global headquarters, effective early 2016. This move will enable the executive leadership team to be closer to operations in Chicago and Milwaukee, while remaining near an international transportation hub.

Headquarters were previously in Amersham, U.K., which remains a major location for GE Healthcare with its global Life Sciences head office and base for U.K. operations.

John Flannery, President and CEO of GE Healthcare, said: “We are excited to strengthen GE’s roots in Chicago, where we will continue our focus on being the leading provider of outcome-based solutions for the healthcare industry.  Chicago has a rich industrial heritage, terrific international transportation links and is close to some of the world’s leading healthcare and academic institutions.  It is also ideally located for many of GE Healthcare’s operations.”

Rahm Emanuel, mayor of the City of Chicago, said: “GE Healthcare’s decision to relocate its global headquarters here is another example of Chicago’s growing strength in healthcare and innovation, and another vote of confidence in Chicago’s economic future. In relocating, GE Healthcare sees several fundamental strengths in Chicago – from our talent to our transportation – that will help them build a great future and remain on the industry’s cutting edge.”

Illinois Gov. Bruce Rauner said: “The relocation of GE Healthcare's global headquarters to Chicago is a tremendous win for the state of Illinois. GE Healthcare will help grow the economy in Illinois by investing in our communities and building Chicago's reputation as a global business hub. GE Healthcare joins a preeminent life sciences industry in Illinois and I am happy to welcome them to their new home.”

For more information: www.gehealthcare.com


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now